What FDA approval of the Pfizer vaccine means for a hard-hit state
1 big thing
Axios
4.0 • 2K Ratings
🗓️ 24 August 2021
⏱️ 11 minutes
🧾️ Download transcript
Summary
Transcript
Click on a timestamp to play from that location
| 0:00.5 | This episode is brought to you by London Business School. |
| 0:03.6 | Looking to accelerate your business or understand the opportunities in AI or ESG, |
| 0:08.7 | are you thinking about taking the plunge into entrepreneurship, |
| 0:11.6 | or about what leadership skills will take you to the next level? |
| 0:14.8 | To listen to the latest insights and discussion from LBS faculty, |
| 0:18.5 | subject experts and industry insiders, look for podcasts from London Business School. |
| 0:23.6 | Navigate the now and be prepared for what's next with London Business School. |
| 0:30.8 | Good morning. Welcome to Axios today. |
| 0:35.3 | It's Tuesday, August 24th. I'm Margaret Talif in for Nila Boudou. |
| 0:40.4 | Here's what we're watching today. |
| 0:42.1 | Dyer conditions and couture for evacuees from Afghanistan. |
| 0:45.5 | Plus, FDA approval of the Pfizer vaccine raises questions about young kids. |
| 0:51.2 | But first, today's one big thing. |
| 0:53.9 | What that FDA approval means for vaccination rates in a hard-hit state. |
| 1:00.3 | The FDA yesterday granted full approval to the Pfizer BioNTech COVID vaccine. |
| 1:05.6 | Will it convince more people to get vaccinated though? |
| 1:08.4 | The answer to that question will be especially important in states with low vaccination rates |
| 1:12.6 | and surging hospitalizations like Alabama. |
| 1:15.6 | That state is currently one of the hardest hit by COVID in the nation. |
| 1:19.9 | Dr. Scott Harris is the state health officer for the Department of Public Health in Alabama. |
| 1:24.2 | Dr. Harris, good morning. Good morning. |
| 1:26.9 | We last spoke with you in December just before the public really started getting the vaccine |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Axios, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Axios and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.

